blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3210608

EP3210608 - SOLID PHARMACEUTICAL COMPOSITION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.08.2022
Database last updated on 24.08.2024
FormerExamination is in progress
Status updated on  24.07.2020
FormerRequest for examination was made
Status updated on  28.07.2017
FormerThe international publication has been made
Status updated on  28.04.2017
Most recent event   Tooltip26.08.2022Application deemed to be withdrawnpublished on 28.09.2022  [2022/39]
Applicant(s)For all designated states
Kyorin Pharmaceutical Co., Ltd.
6, Kanda Surugadai 4-chome
Chiyoda-ku
Tokyo 101-8311 / JP
[2017/35]
Inventor(s)01 / UCHIDA, Hiroshi
c/o WATARASE Research Center
KYORIN PHARMACEUTICAL CO. LTD.
1848 Nogi
Nogi-machi, Shimotsuga-gun
Tochigi 329-0114 / JP
02 / HANADA, Masataka
c/o WATARASE Research Center
KYORIN PHARMACEUTICAL CO. LTD.
1848 Nogi
Nogi-machi, Shimotsuga-gun
Tochigi 329-0114 / JP
 [2017/35]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2017/35]
Application number, filing date15853138.423.10.2015
[2017/35]
WO2015JP05344
Priority number, dateJP2014021651523.10.2014         Original published format: JP 2014216515
[2017/35]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016063544
Date:28.04.2016
Language:JA
[2016/17]
Type: A1 Application with search report 
No.:EP3210608
Date:30.08.2017
Language:EN
[2017/35]
Search report(s)International search report - published on:JP28.04.2016
(Supplementary) European search report - dispatched on:EP24.05.2018
ClassificationIPC:A61K31/4709, A61K9/20, A61P31/04, A61K9/28
[2018/25]
CPC:
A61K31/4709 (EP,US); A61K9/20 (US); A61K9/2018 (EP,US);
A61K9/2054 (EP,US); A61K9/2095 (EP,US); A61K9/2853 (EP,US);
A61K9/2866 (EP,US); A61P31/04 (EP) (-)
Former IPC [2017/35]A61K31/4709, A61K9/20, A61P31/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/35]
TitleGerman:FESTE PHARMAZEUTISCHE ZUSAMMENSETZUNG[2017/35]
English:SOLID PHARMACEUTICAL COMPOSITION[2017/35]
French:COMPOSITION PHARMACEUTIQUE SOLIDE[2017/35]
Entry into regional phase28.04.2017Translation filed 
23.05.2017National basic fee paid 
23.05.2017Search fee paid 
23.05.2017Designation fee(s) paid 
23.05.2017Examination fee paid 
Examination procedure28.04.2017Date on which the examining division has become responsible
23.05.2017Examination requested  [2017/35]
12.12.2018Amendment by applicant (claims and/or description)
23.07.2020Despatch of a communication from the examining division (Time limit: M04)
19.11.2020Reply to a communication from the examining division
03.05.2022Application deemed to be withdrawn, date of legal effect  [2022/39]
24.05.2022Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2022/39]
Fees paidRenewal fee
23.10.2017Renewal fee patent year 03
22.10.2018Renewal fee patent year 04
23.10.2019Renewal fee patent year 05
23.10.2020Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.10.202107   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XD]EP2778159  (KYORIN SEIYAKU KK [JP]) [XD] 1 * abstract * * paragraph [0045] *;
 [XP]WO2014174846  (KYORIN SEIYAKU KK [JP]) [XP] 1-8 * abstract * * reference example 4 *;
 [E]EP2990038  (KYORIN SEIYAKU KK [JP]) [E] 1-8 * abstract ** reference example 4 *
International search[X]WO2013069297  (KYORIN SEIYAKU KK [JP]) [X] 1-8 * , particularly, claims 5 to 8, 14 to 16; examples 2, 8 & EP 2778159 A1 claims 5 to 8, 14 to 16; examples 2, 8 & US 2014/0288310 A1 & AU 2012337206 A & CA 2855022 A & CN 103930414 A & KR 10-2014-0098074 A *;
 [A]WO2013145749  (KYORIN SEIYAKU KK [JP]) [A] 1-8 * , (Family: none) *;
 [A]WO2013145750  (KYORIN SEIYAKU KK [JP]) [A] 1-8 * , (Family: none) *;
 [A]WO2006059716  (TAKEDA PHARMACEUTICAL [JP], et al) [A] 1-8 * , & US 2008/0031942 A1 & EP 1825866 A1 *;
 [A]JP2013043834  (OHARA YAKUHIN KOGYO KK) [A] 1-8 * , (Family: none) *;
 [A]JP2002505290  (Daewoong Pharmaceutical Co., Ltd.) [A] 1-8 * , & WO 1999/044614 A1 & EP 1066040 A & DE 69905452 D & KR 10-0299356 B1 & AU 3277899 A & CA 2322432 A *;
 [A]WO2006059716  (TAKEDA PHARMACEUTICAL [JP], et al) [A] 1-8 * , & US 2008/0031942 A1 & EP 1825866 A1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.